-
Abu Dhabi Launches First Clinical Trial for AAV Gene Therapy Targeting MerTK-Related Retinitis Pigmentosa
Mar 23 2026 -
Sensorion Reports Six-Month Audiogene Data for AAV Gene Therapy SENS-501 and Advances GJB2 Program Toward Clinical Trials
Mar 23 2026 -
Poseida Therapeutics Positions for Next Wave of Allogeneic CAR-T Innovation
Mar 19 2026 -
Sensorion Advances AAV Gene Therapy Pipeline in Genetic Hearing Loss
Mar 19 2026 -
UCSF Scientists Enable Direct In Vivo CAR-T Engineering Using Dual-Vector System
Mar 18 2026 -
Sarepta Therapeutics Advances AAV Gene Therapy Safety Strategy in Duchenne Trial
Mar 18 2026 -
Specific Biologics Secures Funding to Advance AI-Driven Genome Editing Platform for ALS and Beyond
Mar 18 2026 -
U.S. Food and Drug Administration Expands RMAT Eligibility to Therapies on Clinical Hold
Mar 18 2026 -
Innorna Secures FDA Clearance for Phase 1 mRNA Therapy in Refractory Gout
Mar 17 2026